Healthcare -
Biotechnology - NASDAQ - US
$ 0.906
1.56 %
$ 41.5 M
Market Cap
-0.58
P/E
XLO - LONG-TERM DEBT
Long-term Debt XLO - Xilio Therapeutics, Inc.
8.14 M
LAST VALUE
-35.77%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR